Best for ambulatory HCC capture and value-based care
35/50
6th of 6
| Capture accuracy | Traceability & auditability | Revenue & denial impact | EHR & deployment | Access & transparency |
|---|---|---|---|---|
| 8/10 | 8/10 | 8/10 | 7/10 | 4/10 |
- Best for
- Primary care and risk-bearing ambulatory groups that need longitudinal chart synthesis, HCC suspecting and point-of-care evidence linked back to labs and specialist notes.
- Limitation
- Purpose-built for outpatient value-based care and HCC workflows rather than inpatient DRG and acute utilization review.
- Price
- Enterprise and medical-group licensing, sales-led
Dimension-by-dimension rubric criteria for AI CDI and utilization review
- Capture accuracy8/10
Category high: 9/10
How reliably the tool finds genuine documentation gaps — diagnosis specificity, HCC recapture, severity and acuity capture — without flooding reviewers with false positives.
- Traceability & auditability8/10
Category high: 10/10
Whether every suggested code or query anchors to a verbatim phrase in the record, and whether the audit trail would survive a payer or RAC review.
- Revenue & denial impact8/10
Category high: 9/10
Documented effect on case mix index, DRG accuracy, denial rates and appeal outcomes, weighted toward externally reported results over vendor claims.
- EHR & deployment7/10
Category high: 10/10
Depth of EHR integration, concurrent versus retrospective review support, reviewer worklist prioritization, and the implementation burden on IT and HIM.
- Access & transparency4/10
Category high: 8/10
Published pricing, evaluation path, and whether a clinician or a small group can trial the tool without an enterprise procurement cycle.